Medscape

Can Dual Immunotherapy Replace Surgery in Gastric Cancer?

A small Italian study suggests a way to safely reduce gastrectomy rates in microsatellite instability-high disease.
Seeking Alpha

ENHERTU® Followed by THP Before Surgery Resulted in a Pathologic Complete Response in 67% of Patients with High-Risk HER2 Positive Early-Stage Breast Cancer in DESTINY ...

TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)-- Positive results from the DESTINY-Breast11 phase 3 trial showed ENHERTU ® (trastuzumab deruxtecan) followed by paclitaxel, trastuzumab and pertuzumab ...
ascopubs.org

Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial

Automated Lugano Metabolic Response Assessment in 18F-Fluorodeoxyglucose–Avid Non-Hodgkin Lymphoma With Deep Learning on 18F-Fluorodeoxyglucose–Positron Emission Tomography OPTICAL was a randomized, ...
ascopubs.org

Comparison of postoperative adjuvant therapy and surgery alone in pathological N1-2 esophageal squamous cell carcinoma: A prospective multi-center randomized controlled trial.

Improving evidence-based treatment selection and patient-centered care in upper GI cancers: A Project ECHO initiative. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...
Hosted on MSN

Immunotherapy before surgery shows major survival gains

Two landmark trials in lung and bowel cancer show that giving immunotherapy before surgery significantly improves survival ...